FDA Commissioner on steps to promote development of generic versions of opioids formulated to deter abuse
Goya Voluntary Recall of Adobo Because of Possible Health Risk
Goya de Puerto Rico is recalling 28 ounces Adobo with Cumin
Seasoning and 28 ounces Adobo with Pepper Seasoning because
they have the potential to be contaminated with Salmonella, an
organism which can cause serious and sometimes fatal infections
in young children, frail or elderly people, and others with weakened
immune system.
Casa Sanchez Foods Extiende El Retiro Voluntario Del " Real Guacamole " Para Incluir “Spicy Guacamole” Del Mercado Por Causa De Posible Riesgo Para La Salud
Casa Sanchez Foods de Hayward, California, está retirando todo su “Real Guacamole” y “Spicy Guacamole” del mercado, por precaución de acuerdo con el compromiso de la compañía para proteger la salud pública. La retirada fue necesaria por los resultados de pruebas positivas para Listeria monocytogenes en dos paquetes de muchas muestras recogidas para el programa de pruebas de muestras aleatorias de la Administración de Drogas y Alimentos de EE. UU.
Expanded Voluntary Recall for Casa Sanchez Foods "Real Guacamole" and to also Include “Spicy Guacamole” Because of Possible Health Risk
Casa Sanchez Foods of Hayward, CA, is voluntarily recalling all “Real Guacamole” and “Spicy Guacamole” products out of an abundance of caution in keeping with the company’s commitment to protect the public health. The recall was necessitated by positive test results for Listeria monocytogenes on two packages out of many samples collected for the U. S. Food and Drug Administration random sample testing program.
FDA approves first telehealth option to program cochlear implants remotely
FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls
Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts by the agency to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls
Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets
For Immediate Release – PEAPACK, NJ, November 16, 2017 – Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the potential to be super potent or sub potent.
Lipari Foods, LLC. Issues Voluntary Product Recall of Specific Dark Chocolate Products Due to Undeclared Milk Allergen
Lipari Foods, LLC has issued a voluntary recall of specific dark chocolate products packaged by sister company JLM due to an undeclared milk allergen. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume these products. The products are safe for consumption by those who do not have an allergy or severe sensitivity to milk.
FDA expands approval of Sutent to reduce the risk of kidney cancer returning
FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.
FDA approves new treatment to prevent bleeding in certain patients with hemophilia A
FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors.